Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H8N2O |
Molecular Weight | 220.2261 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1C=CC2=C3N1C4=C(C=CC=C4)C3=CC=N2
InChI
InChIKey=ZERVJPYNQLONEK-UHFFFAOYSA-N
InChI=1S/C14H8N2O/c17-13-6-5-11-14-10(7-8-15-11)9-3-1-2-4-12(9)16(13)14/h1-8H
Molecular Formula | C14H8N2O |
Molecular Weight | 220.2261 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Canthin-6-one is a natural product isolated from various plant genera and from fungi with potential antitumor activity. It induces cell death, cell cycle arrest and differentiation in human myeloid leukemia cells. Canthin-6-one is main compound isolated from Zanthoxylum chiloperone var angustifolium with broad spectrum antifungal, leishmanicidal and trypanocidal activities. Canthin-6-one exhibited trypanocidal activity in vivo in the mouse model of acute
or chronic infection. Canthin-6-one exhibited a broad spectrum of activities against Aspergillus fumigatus, A. niger, A. terreus, Candida albicans, C. tropicalis, C. glabrata, Cryptococcus neoformans, Geotrichum candidum, Saccharomyces cerevisiae, Trichosporon beigelii, Trichosporon cutaneum and Trichophyton mentagrophytes var. interdigitale with MICs values between 5.3 and 46 umol/L.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27092482
Curator's Comment: Canthin-6-one was first isolated in 1952 by Haynes et al. from the Australian tree Pentaceras australis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: map04210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25379743 |
|||
Target ID: CHEMBL612241 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12007711 |
|||
Target ID: CHEMBL368 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16949231 |
|||
Target ID: CHEMBL366 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12820240 |
|||
Target ID: CHEMBL2367317 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12820240 |
|||
Target ID: CHEMBL612874 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12820240 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12007711
The mice were treated for 5 weeks postinfection with Canthin-6-one by oral (14 days) or intralesional route (4 days) at 10 mg/kg daily.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28161479
Canthin-6-one induced cell cycle arrest at G0/G1 (7uM) and G2 (45uM) evidenced by DNA content, BrdU incorporation and cyclin B1/histone 3 quantification in Kasumi-1 human myeloid leukemia cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:03:49 GMT 2023
by
admin
on
Sat Dec 16 09:03:49 GMT 2023
|
Record UNII |
3FK17S759N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
97176
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY | |||
|
3363
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY | |||
|
479-43-6
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY | |||
|
103003
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY | |||
|
DTXSID40197322
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY | |||
|
3FK17S759N
Created by
admin on Sat Dec 16 09:03:49 GMT 2023 , Edited by admin on Sat Dec 16 09:03:49 GMT 2023
|
PRIMARY |